Twist Bioscience Corporation (TWST) stock analysis
In our weekly check, Twist Bioscience Corporation is graded D (A to F). Of 21 checks on debt, profit, cash flow and trend: 11 pass, warnings: 1, red flags: 9.
About Twist Bioscience Corporation
Twist Bioscience Corporation is a Healthcare company (Diagnostics & Research) based in the United States, listed on NASDAQ as TWST.
What our checks show for TWST
Red flags
- Weak EPS forecast
- Earnings per share fell 16.7% a year over the last 3 years.
- The company is losing money: the net margin is -28.3%.
- Free cash flow is negative (-16.5% of revenue): the business spends more cash than it brings in.
- The price swings a lot: 83.6% annual volatility. Expect large ups and downs.
- The stock has fallen as much as 94% from a peak. Would you have held through that?
- Beta 2.22: the stock usually moves more than the market, both up and down.
- Return on capital (ROCE) is zero or negative: the business does not earn on the money put into it.
- Free cash flow is negative, so no cash is left over to cover pay in shares.
Warning signs
- The stock is still below its previous peak.
Strengths
- Debt is low: 0.11x equity.
- The net margin rose by 78.7 points over 5 years, to -28.3%.
- The gross margin is 52.4% and has risen by 11 points: pricing power is holding.
- Analysts expect revenue to grow about 19.4% a year over the next years.
- Analysts expect the net margin to improve by 26 points from today's -28.3%.
- Revenue grew 23.3% a year over the last 3 years.
Next earnings report: 2027-02-01
Similar companies
AXSM · ORKA · IMVT · TXG · ABVX · KOD
Questions
What grade does Twist Bioscience Corporation (TWST) have?
In our weekly check, Twist Bioscience Corporation is graded D (A to F). Of 21 checks on debt, profit, cash flow and trend: 11 pass, warnings: 1, red flags: 9. The grade is a risk check, not a buy or sell recommendation.
What are the main risks of TWST stock?
This week's biggest flags for Twist Bioscience Corporation: Weak EPS forecast, Weak EPS growth, Thin margins. In total 10 of 21 checks show a warning or a red flag.
What does Twist Bioscience Corporation do?
Twist Bioscience Corporation is a Healthcare company (Diagnostics & Research) based in the United States, listed on NASDAQ as TWST.
When does Twist Bioscience Corporation report earnings next?
The next earnings report is expected on 2027-02-01. We re-run the checks every week, so the grade can change after it.
The grade is a risk check, not a price forecast, and not investment advice. In our 10-year test (S&P 500, 2016-2026), stocks we graded A or B fell more than 30% 2-3 times less often than D or F, without a lower average return.
Updated 2026-11-14
Open the full analysis